4 | Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
02/2024
-
01/2022 |
3 | Anti-Bacterial Agents (Antibiotics)IBA
04/2024
-
01/2022 |
3 | TroponinIBA
12/2022
-
10/2018 |
3 | Vitamin DFDA LinkGeneric
01/2022
-
06/2017 |
3 | NanocapsulesIBA
04/2021
-
01/2021 |
3 | LipidsIBA
04/2021
-
01/2021 |
2 | omega-Chloroacetophenone (Mace)IBA
08/2021
-
10/2018 |
2 | ferrocifenIBA
02/2021
-
01/2021 |
1 | Colistin (Coly-Mycin)FDA Link
04/2024 |
1 | Hemoglobins (Hemoglobin)IBA
02/2024 |
1 | CreatinineIBA
02/2024 |
1 | FosfomycinFDA Link
07/2022 |
1 | Tromethamine (Trometamol)FDA Link
07/2022 |
1 | Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 |
1 | Oxygen (Dioxygen)IBA
01/2022 |
1 | Cholecalciferol (Vitamin D3)FDA Link
01/2022 |
1 | Immunoglobulins (Immunoglobulin)IBA
10/2021 |
1 | gamma-Globulins (gamma-Globulin)IBA
10/2021 |
1 | HydrogelsIBA
07/2021 |
1 | N-vinyl-2-pyrrolidinoneIBA
04/2021 |
1 | imidazoleIBA
04/2021 |
1 | ruxolitinibIBA
01/2021 |
1 | N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
01/2021 |
1 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
01/2021 |
1 | Janus Kinase InhibitorsIBA
01/2021 |
1 | Janus KinasesIBA
01/2021 |
1 | fedratinibIBA
01/2021 |
1 | Vitamin KFDA Link
12/2020 |
1 | Contrast MediaIBA
01/2020 |
1 | Biomarkers (Surrogate Marker)IBA
01/2019 |
1 | Silicon Dioxide (Silica)FDA LinkGeneric
01/2019 |
1 | Voriconazole (Vfend)FDA LinkGeneric
01/2018 |
1 | Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2018 |
1 | hydroxide ionIBA
06/2017 |
1 | VaccinesIBA
01/2016 |
1 | CholesterolIBA
06/2013 |